Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Completed · Not applicable

Conditions studied: Hematopoietic/Lymphoid Cancer

In brief

This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.

Key facts

Study ID

NCT01758484

Run by

Fred Hutchinson Cancer Center

People needed

20

Starts

2013-04-01

Last updated by the study team

2016-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent
• English as primary language
• Planned autologous or allogeneic hematopoietic cell transplantation
• Presence of co-morbidities (hematopoietic cell transplant co-morbidity index [HCT-CI] score 3 or greater), high risk disease (relapse risk > 25%), or a planned type of transplant (human leukocyte antigen [HLA]-mismatched allogeneic or myeloablative) that places the patient at a higher than average risk of non-relapse mortality or relapse

You may not qualify if…

• Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach, as judged by the patient's medical team
• First transplant of a planned tandem procedure (the second transplant is eligible)

Where it is running

• Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.